Department Head
Univ.-Prof. Dr. rer. nat.
Sebastian Preissl
Mail: sebastian.preissl(at)uni-graz.at
Tel.: +43 316 380 - 5570
Institute of Pharmaceutical Sciences
Preissl Lab | Cardiovascular Gene Regulation at the University of Freiburg
| 2024 - | Univ.-Professor, Head of Department Pharmacology and Toxicology, Institute of Pharmaceutical Sciences, University of Graz, Austria |
| 2021 - | Group Leader Institute for Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Germany |
| 2021 - 2024 | Deputy Professor, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Germany |
| 2017 - 2021 | Associate Director, Single Cell Genomics, Center for Epigenomics, UCSD, La Jolla, CA, USA |
| 2015 - 2017 | Postdoctoral Fellow, Ludwig Institute for Cancer Research, La Jolla, CA, USA |
| 2015 | Postdoctoral Fellow, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Germany |
| 2010 - 2015 | PhD, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Germany |
| 2010 | German licensure as pharmacist |
| 2009 - 2010 | Diploma in Pharmacy, European ScreeningPort GmbH, Hamburg, Germany and Institute for Pharmaceutical Sciences, University of Freiburg, Germany |
| 2004 - 2009 | Study of Pharmacy, University of Freiburg, Germany |
Publications
Additional homepage
Deputy Department Heads
| +43 316 380 - 5565 Institut für Pharmazeutische Wissenschaften |
| +43 316 380 - 5559 Institut für Pharmazeutische Wissenschaften Mittwoch 10:00-11:00; in den Ferien nach Rücksprache |
Research Overview
The research at the department of Pharmacology and Toxicology is dedicated to a variety of exciting topics to understand both disease mechanisms and physiological processes at the cellular and molecular level. Our broad research interests span several areas, including the molecular mechanisms of cardiovascular disease, kidney disease, inflammatory processes, various aspects of obesity-related health risks, signaling in the vasculature and degenerative joint disease.
The common goal of our interdisciplinary team of scientists from different disciplines is to gain an in-depth understanding of disease mechanisms to develop innovative approaches for prevention, diagnosis and therapy.